AstraZeneca reinforces commitment to protecting the most vulnerable from serious infectious diseases at IDWeek 2023

Real-world data from INFORM study demonstrate increased risk of severe COVID-19
outcomes among all individuals with immunocompromising conditions
and highlight need for additional protection

FluMist Quadrivalent data support the potential for a self-administered influenza vaccine to expand
access to an important tool for prevention

/Public Release. View in full here.